InspireMD (NYSE: NSPR) reported Q2 EPS of ($0.19), $0.02 worse than the analyst estimate of ($0.17). Revenue for the quarter came in at $540 thousand versus the consensus estimate of $800 thousand.

For earnings history and earnings-related data on InspireMD (NSPR) click here.